Screener
AptarGroup ATR Pharma — Goodwill, Acquired During Period
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AptarGroup in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The source filing: AptarGroup’s 10-K, filed February 6, 2026.
- Filed
- Feb 6, 2026, 11:57 AM EST
- Fiscal year
- FY2025
- Accession
- 0000896622-26-000007
| Line item | Pharma | Beauty | Closures | Total |
|---|---|---|---|---|
| Balance as of December 31, 2023 | $508,447 | $287,097 | $167,874 | $963,418 |
| Foreign currency exchange effects | (20,213) | (5,811) | (1,138) | (27,162) |
| Balance as of December 31, 2024 | $488,234 | $281,286 | $166,736 | $936,256 |
| Acquisitions | 9,397 | 76,183 | — | 85,580 |
| Foreign currency exchange effects | 41,072 | 13,379 | 1,611 | 56,062 |
| Balance as of December 31, 2025 | $538,703 | $370,848 | $168,347 | $1,077,898 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is AptarGroup's pharma — goodwill, acquired during period?
- AptarGroup (ATR) reported pharma — goodwill, acquired during period of $2.35M in Q4 2025.
- What does pharma — goodwill, acquired during period mean?
- The premium paid over the fair value of net identifiable assets when acquiring businesses specifically integrated into the Pharma segment. This reflects the value of intangible synergies, market access, and intellectual property gained through M&A activity.
Ask your AI about AptarGroup's pharma — goodwill, acquired during period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude